Literature DB >> 32927482

MGMT promoter methylation and hypermutant recurrence in IDH mutant lower-grade glioma.

Julie J Miller1,2, Daniel P Cahill1,3.   

Abstract

Entities:  

Keywords:  IDH1 mutation; glioma; temozolomide

Year:  2020        PMID： 32927482      PMCID： PMC7690349          DOI： 10.1093/neuonc/noaa212

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  22 in total

1.  Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment.

Authors:  Hinke F van Thuijl; Tali Mazor; Brett E Johnson; Shaun D Fouse; Koki Aihara; Chibo Hong; Annika Malmström; Martin Hallbeck; Jan J Heimans; Jenneke J Kloezeman; Marie Stenmark-Askmalm; Martine L M Lamfers; Nobuhito Saito; Hiroyuki Aburatani; Akitake Mukasa; Mitchell S Berger; Peter Söderkvist; Barry S Taylor; Annette M Molinaro; Pieter Wesseling; Jaap C Reijneveld; Susan M Chang; Bauke Ylstra; Joseph F Costello
Journal:  Acta Neuropathol       Date:  2015-02-28       Impact factor: 17.088

2.  MGMT promoter methylation level in newly diagnosed low-grade glioma is a predictor of hypermutation at recurrence.

Authors:  Radhika Mathur; Yalan Zhang; Matthew R Grimmer; Chibo Hong; Michael Zhang; Saumya Bollam; Kevin Petrecca; Jennifer Clarke; Mitchel S Berger; Joanna J Phillips; Nancy Ann Oberheim-Bush; Annette M Molinaro; Susan M Chang; Joseph F Costello
Journal:  Neuro Oncol       Date:  2020-11-26       Impact factor: 12.300

3.  Radiation plus Procarbazine, CCNU, and Vincristine in Low-Grade Glioma.

Authors:  Jan C Buckner; Edward G Shaw; Stephanie L Pugh; Arnab Chakravarti; Mark R Gilbert; Geoffrey R Barger; Stephen Coons; Peter Ricci; Dennis Bullard; Paul D Brown; Keith Stelzer; David Brachman; John H Suh; Christopher J Schultz; Jean-Paul Bahary; Barbara J Fisher; Harold Kim; Albert D Murtha; Erica H Bell; Minhee Won; Minesh P Mehta; Walter J Curran
Journal:  N Engl J Med       Date:  2016-04-07       Impact factor: 91.245

4.  Interim results from the CATNON trial (EORTC study 26053-22054) of treatment with concurrent and adjuvant temozolomide for 1p/19q non-co-deleted anaplastic glioma: a phase 3, randomised, open-label intergroup study.

Authors:  Martin J van den Bent; Brigitta Baumert; Sara C Erridge; Michael A Vogelbaum; Anna K Nowak; Marc Sanson; Alba Ariela Brandes; Paul M Clement; Jean Francais Baurain; Warren P Mason; Helen Wheeler; Olivier L Chinot; Sanjeev Gill; Matthew Griffin; David G Brachman; Walter Taal; Roberta Rudà; Michael Weller; Catherine McBain; Jaap Reijneveld; Roelien H Enting; Damien C Weber; Thierry Lesimple; Susan Clenton; Anja Gijtenbeek; Sarah Pascoe; Ulrich Herrlinger; Peter Hau; Frederic Dhermain; Irene van Heuvel; Roger Stupp; Ken Aldape; Robert B Jenkins; Hendrikus Jan Dubbink; Winand N M Dinjens; Pieter Wesseling; Sarah Nuyens; Vassilis Golfinopoulos; Thierry Gorlia; Wolfgang Wick; Johan M Kros
Journal:  Lancet       Date:  2017-08-08       Impact factor: 79.321

5.  Genomic Correlates of Disease Progression and Treatment Response in Prospectively Characterized Gliomas.

Authors:  Philip Jonsson; Andrew L Lin; Robert J Young; Natalie M DiStefano; David M Hyman; Bob T Li; Michael F Berger; Ahmet Zehir; Marc Ladanyi; David B Solit; Angela G Arnold; Zsofia K Stadler; Diana Mandelker; Michael E Goldberg; Juliann Chmielecki; Maryam Pourmaleki; Shahiba Q Ogilvie; Shweta S Chavan; Andrew T McKeown; Malbora Manne; Allison Hyde; Kathryn Beal; T Jonathan Yang; Craig P Nolan; Elena Pentsova; Antonio Omuro; Igor T Gavrilovic; Thomas J Kaley; Eli L Diamond; Jacqueline B Stone; Christian Grommes; Adrienne Boire; Mariza Daras; Anna F Piotrowski; Alexandra M Miller; Philip H Gutin; Timothy A Chan; Viviane S Tabar; Cameron W Brennan; Marc Rosenblum; Lisa M DeAngelis; Ingo K Mellinghoff; Barry S Taylor
Journal:  Clin Cancer Res       Date:  2019-07-01       Impact factor: 12.531

6.  MGMT gene silencing and benefit from temozolomide in glioblastoma.

Authors:  Monika E Hegi; Annie-Claire Diserens; Thierry Gorlia; Marie-France Hamou; Nicolas de Tribolet; Michael Weller; Johan M Kros; Johannes A Hainfellner; Warren Mason; Luigi Mariani; Jacoline E C Bromberg; Peter Hau; René O Mirimanoff; J Gregory Cairncross; Robert C Janzer; Roger Stupp
Journal:  N Engl J Med       Date:  2005-03-10       Impact factor: 91.245

7.  Accelerated progression of IDH mutant glioma after first recurrence.

Authors:  Julie J Miller; Franziska Loebel; Tareq A Juratli; Shilpa S Tummala; Erik A Williams; Tracy T Batchelor; Isabel Arrillaga-Romany; Daniel P Cahill
Journal:  Neuro Oncol       Date:  2019-05-06       Impact factor: 12.300

8.  ABT-888 restores sensitivity in temozolomide resistant glioma cells and xenografts.

Authors:  Alice L Yuan; Christian B Ricks; Alexandra K Bohm; Xueqing Lun; Lori Maxwell; Shahana Safdar; Shazreh Bukhari; Amanda Gerber; Wajid Sayeed; Elizabeth A Bering; Haley Pedersen; Jennifer A Chan; Yaoqing Shen; Marco Marra; David R Kaplan; Warren Mason; Lindsey D Goodman; Ravesanker Ezhilarasan; Ascher B Kaufmann; Matthew Cabral; Steve M Robbins; Donna L Senger; Daniel P Cahill; Erik P Sulman; J Gregory Cairncross; Michael D Blough
Journal:  PLoS One       Date:  2018-08-28       Impact factor: 3.240

9.  Mechanisms and therapeutic implications of hypermutation in gliomas.

Authors:  Mehdi Touat; Yvonne Y Li; Adam N Boynton; Liam F Spurr; J Bryan Iorgulescu; Craig L Bohrson; Isidro Cortes-Ciriano; Cristina Birzu; Jack E Geduldig; Kristine Pelton; Mary Jane Lim-Fat; Sangita Pal; Ruben Ferrer-Luna; Shakti H Ramkissoon; Frank Dubois; Charlotte Bellamy; Naomi Currimjee; Juliana Bonardi; Kenin Qian; Patricia Ho; Seth Malinowski; Leon Taquet; Robert E Jones; Aniket Shetty; Kin-Hoe Chow; Radwa Sharaf; Dean Pavlick; Lee A Albacker; Nadia Younan; Capucine Baldini; Maïté Verreault; Marine Giry; Erell Guillerm; Samy Ammari; Frédéric Beuvon; Karima Mokhtari; Agusti Alentorn; Caroline Dehais; Caroline Houillier; Florence Laigle-Donadey; Dimitri Psimaras; Eudocia Q Lee; Lakshmi Nayak; J Ricardo McFaline-Figueroa; Alexandre Carpentier; Philippe Cornu; Laurent Capelle; Bertrand Mathon; Jill S Barnholtz-Sloan; Arnab Chakravarti; Wenya Linda Bi; E Antonio Chiocca; Katie Pricola Fehnel; Sanda Alexandrescu; Susan N Chi; Daphne Haas-Kogan; Tracy T Batchelor; Garrett M Frampton; Brian M Alexander; Raymond Y Huang; Azra H Ligon; Florence Coulet; Jean-Yves Delattre; Khê Hoang-Xuan; David M Meredith; Sandro Santagata; Alex Duval; Marc Sanson; Andrew D Cherniack; Patrick Y Wen; David A Reardon; Aurélien Marabelle; Peter J Park; Ahmed Idbaih; Rameen Beroukhim; Pratiti Bandopadhayay; Franck Bielle; Keith L Ligon
Journal:  Nature       Date:  2020-04-15       Impact factor: 49.962

10.  Longitudinal molecular trajectories of diffuse glioma in adults.

Authors:  Floris P Barthel; Kevin C Johnson; Frederick S Varn; Anzhela D Moskalik; Georgette Tanner; Emre Kocakavuk; Kevin J Anderson; Olajide Abiola; Kenneth Aldape; Kristin D Alfaro; Donat Alpar; Samirkumar B Amin; David M Ashley; Pratiti Bandopadhayay; Jill S Barnholtz-Sloan; Rameen Beroukhim; Christoph Bock; Priscilla K Brastianos; Daniel J Brat; Andrew R Brodbelt; Alexander F Bruns; Ketan R Bulsara; Aruna Chakrabarty; Arnab Chakravarti; Jeffrey H Chuang; Elizabeth B Claus; Elizabeth J Cochran; Jennifer Connelly; Joseph F Costello; Gaetano Finocchiaro; Michael N Fletcher; Pim J French; Hui K Gan; Mark R Gilbert; Peter V Gould; Matthew R Grimmer; Antonio Iavarone; Azzam Ismail; Michael D Jenkinson; Mustafa Khasraw; Hoon Kim; Mathilde C M Kouwenhoven; Peter S LaViolette; Meihong Li; Peter Lichter; Keith L Ligon; Allison K Lowman; Tathiane M Malta; Tali Mazor; Kerrie L McDonald; Annette M Molinaro; Do-Hyun Nam; Naema Nayyar; Ho Keung Ng; Chew Yee Ngan; Simone P Niclou; Johanna M Niers; Houtan Noushmehr; Javad Noorbakhsh; D Ryan Ormond; Chul-Kee Park; Laila M Poisson; Raul Rabadan; Bernhard Radlwimmer; Ganesh Rao; Guido Reifenberger; Jason K Sa; Michael Schuster; Brian L Shaw; Susan C Short; Peter A Sillevis Smitt; Andrew E Sloan; Marion Smits; Hiromichi Suzuki; Ghazaleh Tabatabai; Erwin G Van Meir; Colin Watts; Michael Weller; Pieter Wesseling; Bart A Westerman; Georg Widhalm; Adelheid Woehrer; W K Alfred Yung; Gelareh Zadeh; Jason T Huse; John F De Groot; Lucy F Stead; Roel G W Verhaak
Journal:  Nature       Date:  2019-11-20       Impact factor: 69.504
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.